↓ Skip to main content

Myocardial 123I-metaiodobenzylguanidine imaging in hypertension and left ventricular hypertrophy

Overview of attention for article published in Journal of Nuclear Cardiology, August 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
18 Mendeley
Title
Myocardial 123I-metaiodobenzylguanidine imaging in hypertension and left ventricular hypertrophy
Published in
Journal of Nuclear Cardiology, August 2017
DOI 10.1007/s12350-017-1029-2
Pubmed ID
Authors

Riccardo Liga, Alessia Gimelli, Paolo Marzullo, Giuseppe Ambrosio, Matteo Cameli, Elisabetta Cerbai, Stefano Coiro, Michele Emdin, Rossella Marcucci, Doralisa Morrone, Alberto Palazzuoli, Anna Sonia Petronio, Ketty Savino, Luigi Padeletti, Roberto Pedrinelli, Sezione Regionale Tosco-Umbra On Behalf of Società Italiana di Cardiologia

Abstract

Sympathetic nervous system plays a pivotal role in essential hypertension and in the development of left ventricular hypertrophy. Moreover, cardiac sympathetic dys-regulation has been demonstrated as a key con-causal factor in the genesis and progression of pathologic conditions such as congestive heart failure and ischemic heart disease to which hypertension predisposes as a risk factor. However, despite its fundamental role in cardiac pathophysiology, the evaluation of cardiac sympathetic nervous system has never gained a wide clinical application, remaining mostly a research tool. In this context, nuclear imaging techniques are the only modalities to allow the direct evaluation of cardiac sympathetic nervous integrity, giving the chance to obtain objective measures of the sympathetic tone. This review, while summarizing the general profile of currently available tests for autonomic evaluation, focuses on (123)I-metaiodobenzylguanidine nuclear imaging as a preferential tool to assess cardiac sympathetic status. Specifically, the review discusses the available evidence on cardiac (123)I-metaiodobenzylguanidine scintigraphy in arterial hypertension and left ventricular hypertrophy and its diagnostic and prognostic potential in congestive heart failure and ischemic heart disease.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 22%
Other 3 17%
Student > Bachelor 2 11%
Professor 2 11%
Student > Ph. D. Student 1 6%
Other 3 17%
Unknown 3 17%
Readers by discipline Count As %
Medicine and Dentistry 8 44%
Pharmacology, Toxicology and Pharmaceutical Science 2 11%
Materials Science 1 6%
Biochemistry, Genetics and Molecular Biology 1 6%
Unknown 6 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 August 2017.
All research outputs
#15,989,045
of 25,382,440 outputs
Outputs from Journal of Nuclear Cardiology
#1,105
of 2,044 outputs
Outputs of similar age
#184,560
of 327,545 outputs
Outputs of similar age from Journal of Nuclear Cardiology
#28
of 50 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,044 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 327,545 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.